CoChat

Effects of Chicken Egg Powder, Bovine Colostrum, and Combination Therapy for the Treatment of Gastrointestinal Disorders

Open access
Playford, Raymond John · 2024 · Nutrients

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Abstract

Natural-based products are of interest to the pharmaceutical industry as potential sources of novel medicinal compounds. They are also used by consumers/patients as standalone therapies or as an adjunct to Western medicines. Two natural-based products of interest are chicken egg and bovine colostrum (the milk produced in the first few days following calving). Both products are rich in immunoglobulins, antimicrobial peptides, growth factors, and macro- and micro-nutrients. In vitro, in vivo, and a limited number of clinical studies suggest therapeutic benefits of both components given alone and together. Combination therapy is of particular interest, as preclinical studies suggest synergistic effects on growth, repair, and gut protection, including microbiome-induced damage. This article describes the main constituents of egg and bovine colostrum, studies of their use alone and together for a wide range of conditions, highlights areas requiring further research, and describes novel indications such as GLP-1-associated gut symptoms. While well placed in the food supplement arena, additional high-quality clinical trials are required to establish their benefits in clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu16213684

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Egg and BC have multiple complementary modes of action. Major pathways in enhancing immunity are shown, with the contribution of specific molecules from BC (red), egg (blue), or same molecule in both (green). Major nutrients and growth factors in egg and BC are also shown.
Figure 1 Egg and BC have multiple complementary modes of action. Major pathways in enhancing immunity are shown, with the contribution of specific molecules from BC (red), egg (blue), or same molecule in both (green). Major nutrients and growth factors in egg and BC are also shown.CC BY · PubMed Central
Figure 2 Effect of egg + BC combination therapy on NSAID-induced small intestinal injury in mice and DSS-induced colonic injury in rats. (A) Normal small intestinal villi, (B) villi from animals treated with NSAID alone, (C) villi from animals who received NSAID + egg + BC, (D) normal colon, (E) colon of animals treated with DSS to cause colitis, (F) colon of animals given DSS and egg + BC. Egg + BC resulted in preservation of a nearly normal appearance of villi and colon. Protective effects were significantly higher with egg + BC, rather than egg or BC alone at the same total dose [25]. Images reproduced from Playford et al. [25].
Figure 2 Effect of egg + BC combination therapy on NSAID-induced small intestinal injury in mice and DSS-induced colonic injury in rats. (A) Normal small intestinal villi, (B) villi from animals treated with NSAID alone, (C) villi from animals who received NSAID + egg + BC, (D) normal colon, (E) colon of animals treated with DSS to cause colitis, (F) colon of animals given DSS and egg + BC. Egg + BC resulted in preservation of a nearly normal appearance of villi and colon. Protective effects were significantly higher with egg + BC, rather than egg or BC alone at the same total dose [25]. Images reproduced from Playford et al. [25].CC BY · PubMed Central
Figure 3 Pilot study of the effect of egg + bovine colostrum (BC) on gastrointestinal (GI) symptoms caused by the initiation of glucagon-like peptide-1 (GLP-1) therapy, based on data provided by [94].
Figure 3 Pilot study of the effect of egg + bovine colostrum (BC) on gastrointestinal (GI) symptoms caused by the initiation of glucagon-like peptide-1 (GLP-1) therapy, based on data provided by [94].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 93 references

Research works printed but not linked: 2

  1. Ragab, 2004, Role of Bovine colostrum and its biofunctional fraction PRP in oral treatment of enterogenic endotoxaemia in rats, Int. J. Agric. Biol., 6, 576
  2. implications for clinical trials. PLoS ONE, 15, Erratum in PLoS ONE 2020, 15, e0240392. · DOI

Cited by

See all 4

Metadata

Authors
Playford, R. J.
Affiliations
University of West London (GB)
Corresponding author
Playford, Raymond John
Venue
Nutrients
Publisher
MDPI AG
Published
2024-10-29
Volume
16
Issue
21
Pages
3684
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4403870995
Cited by
4
References
92
Citations by year
2026: 1 · 2025: 3
FWCI
0.14
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Animal Diversity and Health Studies
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Nutrition and Physiology
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
Keywords
bovine colostrum, combination therapy, gastrointestinal diseases, immunoglobulins, antimicrobial peptides, growth factors, gut microbiota, dietary supplements
MeSH terms
Gastrointestinal Microbiome, Animals, Cattle, Chickens, Colostrum, Eggs, Gastrointestinal Diseases, Humans, Powders, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.